Advanced Oncotherapy announces that Michael Sinclair, Executive Chairman of the Company, had yesterday purchased an option over 30 million ordinary shares of 1 penny each in the Company from Brahma AG at a cost of £300,000. The Option vests immediately, expires two years from today’s date and has an exercise price of 10p per Ordinary Share.
Following the above transaction, Michael Sinclair’s interest in the Company is as follows:
Ordinary Shares: 68,079,757
Options over Ordinary Shares: 65,800,000
Warrants over Ordinary Shares: 28,500,000
For further information contact:
Advanced Oncotherapy Plc |
|
Sanjeev Pandya, CEO |
Tel: +44 20 3617 8728 |
Nicholas Serandour, CFO |
|
|
|
Westhouse Securities (Nomad & Joint Broker) |
Tel: +44 20 7601 6100 |
Antonio Bossi / David Coaten |
|
|
|
Beaufort Securities (Joint Broker) |
Tel: +44 20 7382 8300 |
Saif Janjua / Jon Levinson |
|
|
|
Walbrook PR (Financial PR & IR) |
Tel: +44 20 7933 8780 or avo@walbrookpr.com |
Paul McManus / Anna Dunphy |
Mob: +44 7980 541 893 / Mob: +44 7876 741 001 |